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To the best of our knowledge, no reports have directly compared synovial ﬂuid (SF)- and synovial
membrane (SM)-derived mesenchymal stem cells (MSCs) from primary knee osteoarthritis patients in
terms of MSC proportion, either immediately after isolation or during culture. Any possible correlation
between SM- and SF-MSC purity and osteoarthritis severity, also remains unclear. We therefore assessed
quantitative and phenotypic differences in MSCs isolated from SF and SM. We also evaluated the
correlation between sample MSC purity, and disease severity, in patients with osteoarthritis. The main
result of the current study was that the mean SF-MSC proportion at passage 0 was negatively correlated
with KellgreneLawrence (KL) grade (r ¼ 0.565, P ¼ 0.002). In addition, KL grade was a only signiﬁcant
independent negative predictor of SF-MSC proportion at passage 0 (b ¼ 0.356, P ¼ 0.039). Conclusively,
the proportion of SF-MSCs in fresh samples, evaluated at the single cell level, was inversely correlated
with osteoarthritis severity.
 2011 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.Materials and methods
In the present study, all patients who were candidates for total
knee arthroplasty (TKA) because of severe osteoarthritis, or who
had mild-to-moderate osteoarthritis and were scheduled for
arthroscopic partial meniscectomy to treat degenerative medial
meniscus posterior horn tears, were eligible for inclusion. A priori
power analysis was performed to determine the sample size using
the two-sided hypothesis test at an alpha level of 0.05 and a power
of 0.8. In a pilot study of seven cases, 20 knees were found to be
required to detect a signiﬁcant difference between synovial ﬂuid
(SF)- and synovial membrane-mesenchymal stem cell (SM-MSC)
proportions, which was the primary outcome measure in the: K.-M. Lee, Department of
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Elsevier Ltd on behalf of Osteoartpresent study. The current study ultimately involved 28 patients,
indicating adequate power (0.854) for detecting a signiﬁcant
difference between the two proportions.
Of the 35 patients initially approached for the study, 32 patients
agreed to take part. After eligibility assessments, 30 patients were
enrolled. The ﬁnal analysis involved data from 28 patients (two
patients were excluded as the amount of aspirated SFwas too small).
Of the 28 patients with osteoarthritis (four males and 24 females;
mean age, 56 years; age range, 43e76 years), 10 patients underwent
arthroscopic partial meniscectomy and 18 patients underwent TKA.
Preoperatively, the mechanical axis on the side scheduled for
surgery was measured on a standing lower extremity radiograph to
assess the extent of varus deformity. Arthritic changes in the knee
joint were evaluated using KellgreneLawrence (KL) grading.
Hospital for Special Surgery (HSS) scores were also determined to
assess preoperative functional status. SFwas collected from the knee
joint by syringe aspiration before the commencement of surgery. SM
was obtained from the suprapatellar pouch during surgery.
The demographic and preoperative knee characteristics of all
patients are summarized in Supplementary Table I. The study
protocol was approved by our Institutional Review Board (permit no.
AN09041). The detailed information relating to cell isolation and
culture, ﬂow cytometry (Supplementary Fig.1), conﬁrmation ofMSC
multipotentiality, and statistical analysis have been described in the
supplementary method.hritis Research Society International.
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Surface markers and differentiation potential
At passage 1, cultured cells were determined the surface pheno-
type ofMSCs byMSCmarkers CD44 and CD90.Most of cellswere CD
34 negative (81.35% for SF-derived MSCs and 97.48% for SM-derived
MSCs) and CD 44 positive (97.71% and 95.94%, respectively) and CD
90 positive (87.35% and 75.88%, respectively) (Supplementary Fig. 2).
To investigate the multilineage potentiality of SF- and SM-derived
MSCs, cells at passage 1 or 2 were cultured in the adipogenic,
osteogenic, and chondrogenic conditioned media. Both of MSCs
were successfully differentiated into adipocytes [Supplementary
Fig. 3(A, D)], osteocytes [Supplementary Fig. 3(B, E)], and chon-
drocytes [Supplementary Fig. 3(C, F)].
SF- vs SM-derived CD34 CD44þ CD90þ MSCs
At passage 0, the mean proportion of MSCs in cell populations
was lower in SF than in SM samples (1.11  1.22% vs 5.00  2.29%,
P ¼ 0.019). MSC proportions at passage 1 (49.65  17.72% vs
57.58  15.97%, P ¼ 0.759) and passage 2 (59.21  19.47% vs
70.48  15.16%, P ¼ 0.936) were also slightly lower in SF than in SM
cultures, but the difference was not statistically signiﬁcant
(Supplementary Fig. 4). The MSC proportion in both SF and SM
cultures increased markedly with serial passage (F1,27 ¼ 13.19,
P ¼ 0.001). However, no signiﬁcant difference in MSC proliferation
ratewas evident when SM and SF cultures were compared from the
time of initial isolation to passage 2 (F2,26 ¼ 1.78, P ¼ 0.188).
Correlation between MSC proportion and osteoarthritis severity
Of the28patients, three showedKL grade I, seven showedKL grade
II, 10 showed KL grade III, and eight showed KL grade IV. Notably, the
mean SF-MSC proportion at initial isolation (passage 0) variedwith KL
grade (Table I). The mean SF-MSC proportion at passage 0 in samples
from arthritic knees of KL grade 1 or 2 was signiﬁcantly higher than
that of KL grade 3 and 4 samples (1.59 0.97 vs 0.88 1.28, P¼ 0.012).
A negative correlation was evident between the mean SF-MSC
proportion at passage 0 and KL grade (r ¼ 0.565, P ¼ 0.002).
However, no associationwas foundbetweenmeanSF-MSCproportion
at passage 1 or 2, ormean SM-MSCproportion at all passages (0,1, and
2), and KL grade. In addition, no correlation was seen between SF- or
SM-MSC proportion and any of age, extent of preoperative deformity,
HSS score, or body mass index (Supplementary Table II). Multiple
linear regression analysis was performed to determine the effect of
age, bodymass index, KL grade, and varus deformity (mechanical axis)
on SF-MSC proportion at passage 0 (SF P0, %). KL grade was the only
one of those factors found to have an independent effect, and it wasTable I
MSC proportions in culture samples, with respect to KL grades
KL grade
1 2
Mean 95% CI Mean 95% CI
Lower Upper Lower Upper
SF P0 (%) 1.82 0.56 4.20 1.53 0.63 2.42
SF P1 (%) 37.10 33.67 40.53 46.38 33.86 58.88
SF P2 (%) 41.29 2.42 84.99 66.04 56.56 75.51
SM P0 (%) 4.88 2.58 7.17 5.19 2.26 8.12
SM P1 (%) 50.26 46.98 53.53 61.70 44.32 79.08
SM P2 (%) 60.31 8.18 112.44 67.12 49.71 84.53
SD, standard deviation; P, passage; CI, conﬁdence interval.
* P< 0.05.found to be a negative predictor of SF-MSC proportion at passage
0 (b ¼ 0.356, P ¼ 0.039, Table II).
Discussion
We compared the proportion and expandability of MSCs derived
from SF and SM of the osteoarthritic knee and analyzed the
correlation between proportion of SM- or SF-derived MSC cultures
and knee osteoarthritic severity. Our main ﬁndings indicated that
the number of freshly isolated SF-MSCs were lower in proportion
than were SM-MSCs, and that MSC proportion correlated with
osteoarthritic severity.
The isolation of pure MSCs, characterized at the single cell level
at the single cell level, from SF and SM will be invaluable in the
development of novel strategies for expansion of cells that show
consistent and predictable biological activity. In the current study,
the mean proportion of SF-MSCs was lower than that of SM-MSCs
at initial isolation (1.11  1.22% vs 5.00  2.29%, P ¼ 0.019) but
MSC proportions at passage 1 (49.65  17.72% vs 57.58  15.97%,
P ¼ 0.759) and passage 2 (59.21  19.47% vs 70.48  15.16%,
P ¼ 0.936) were similar. These ﬁndings indicate that, although SF
contains fewMSCs, the cells have a robust growth potential even in
severe osteoarthritis, similar to that of SM-MSCs. Accordingly, given
that joint aspiration is easy and minimally invasive, SF should be
considered as a valuable MSC source.
The origin of SF-MSCs remains unclear. Morito et al.1 compared
the SF-MSC numbers in knee reconstruction patients in whom the
anterior cruciate ligament (ACL) was repaired, on days 1 and 6
postoperatively, to evaluate whether bone marrow might be the
origin of such cells. During ACL reconstruction, tunnels were
created into the femoral and tibial bones, and blood from bone,
containing bonemarrow cells, ﬂowed into the joint. Therefore, the
cited authors expected to ﬁnd a higher number of SF-MSCs on
postoperative day 1 than on day 6. In fact, the opposite was
observed; the MSC numbers on day 6 were much higher than on
day 1. This indicates that SF-MSCs originate neither from the bone
marrow nor from circulating MSCs, but rather from the synovium
or cartilage. Not only the synovium, but also the superﬁcial layer
of cartilage, may harbor SF-MSCs, which can be a possible reason
for the increased SF-MSC proportion in samples from early-stage
knee osteoarthritis patients in the result of the present study. It is
now generally accepted that, at least in the articular cartilage of
osteoarthritic patients, an imbalance exists between anabolic and
catabolic pathways, and matrix degradation is favored. In early-
stage osteoarthritis, cartilage wear is conﬁned principally to the
superﬁcial layers, and MSCs from this region are released into the
joint to reconstruct articular cartilage in an effort to rebalance
homeostasis. However, when cartilage destruction develops in
deeper layers, as seen in patients of KL grade 3 or 4, MSCs are noP-value
3 4
Mean 95% CI Mean 95% CI
Lower Upper Lower Upper
1.25 0.04 2.44 0.48 0.16 0.79 0.033*
44.85 29.74 59.95 60.33 49.05 71.60 0.164
57.89 44.95 70.81 59.36 40.03 78.69 0.466
5.02 3.31 6.73 4.84 3.41 6.27 0.979
53.64 40.34 66.93 60.37 50.93 69.80 0.541
71.02 60.48 81.54 74.76 67.11 82.40 0.868
Table II
Multiple linear regression analysis to identify factors affecting the proportion of
SF-MSC at passage 0
Dependent
variables
Independent
variables
Unstandardized
coefﬁcients
Standardized
coefﬁcients
B SE (B) b P-value
SF-MSC P0 (%) Age 0.042 0.035 0.285 0.181
Body mass index 0.051 0.068 0.165 0.429
KL grade 0.298 0.564 0.356 0.039*
Mechanical axis 0.074 0.124 0.221 0.447
B, unstandardized coefﬁcients; SE (B), standard error of B; b, standardized coefﬁ-
cients. The adjusted R2 values for absolute and relative extrusion were 0.166.
Boldface text indicates factors that signiﬁcantly affected SF-MSC proportion at
passage 0.
* P< 0.05.
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of homeostasis in the intra-articular environment might cause
MSCs released from the superﬁcial layer to demonstrate what is
termed “replicative cell senescence”2,3. In line with the results of
our present study, Jones et al.4 reported that SF-MSC levels in
normal human knee joints increased seven-fold in the early stages
of osteoarthritis.
Our study had some inherent limitations. A relatively small
number of patients was enrolled, and we did not have a control
group. Further work using a random sample from a larger pop-
ulation and age-matched normal controls would strengthen our
conclusions. Also, we could not rule out that the MSC populations
analyzed were actually heterogeneous cell populations since the
number of cultured cells was so small that we were unable to sort
for a pure MSC population using ﬂuorescence-activated cell sorting
(FACS). The MSCs used in differentiation experiments were not
FACS sorted and therefore could not be guaranteed to be a pure
population. Another issue relating to this study was that the patient
population was predominantly female. However, a high proportion
of females in the present study may not be considered unusual
since knee osteoarthritis is more prevalent in women than men.
Finally, we did not conﬁrm that our current marker criteria (CD34/
CD44þ/CD90þ) actually identiﬁed only MSCs; markers speciﬁc to
MSCs have not been deﬁned. Despite the explosion of knowledge
on MSCs, no single marker has been identiﬁed that safely identiﬁes
such cells5. Rather, the parallel expression of several cell markers
associated with a multipotent potential toward mesenchymal
differentiation is considered appropriate for identiﬁcation2. The
MSC surface marker identifying criteria recommended by the
International Society for Cellular Therapy state that 95% of any
MSC population must express CD105, CD73, and CD90, and lack
expression (2% positive) of the surface molecules CD45, CD34,
CD14 or CD11b, CD79a or CD19, and human leukocyte antigens
(HLA)-DR6. Of these surface antigens, we selected CD90 and CD34
as positive and negative markers, respectively according to
previous MSC studies7,8. Because many reports5,9 have conﬁrmed
that CD44 is expressed by MSCs, we also included this marker as
a positive criterion for such cells. Despite the limited three epitopes,
the identifying method for MSC in the current study had a strength.
Most previous investigations on MSC reported the percentage of
each surface marker separately, which method did not provide
a quantitative MSC population. However, we could the quantiﬁca-
tion of MSC by ﬁnding the MSC population satisfying simulta-
neously the three surface marker criteria. Furthermore, FACS
analysis using the criteria used here (CD34/CD44þ/CD90þ) has
been validated in the previous work10, as an appropriate method
for identiﬁcation of MSCs.
In conclusion, we characterized MSC proportions, with respect
to total cells, in patient-matched SF and SM samples fromosteoarthritic knees. SM-MSCsweremore plentiful thanwereMSCs
in SF samples. The proportion of SF-MSCs in freshly isolated
samples was inversely correlated with the degree of osteoarthritis
severity.
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